Pro Share Advisors LLC Fulgent Genetics, Inc. Transaction History

Pro Share Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$47.98 - $62.75 $220,180 - $287,959	-4,589 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$49.85 - $96.11 $28,913 - $55,743	-580 Reduced 11.22%	4,589 $286,000
Q4 2021 Feb 08, 2022	BUY	$77.3 - $105.0 $156,532 - $212,625	2,025 Added 64.41%	5,169 $520,000
Q3 2021 Nov 12, 2021	SELL	$74.87 - $110.87 $194,736 - $288,372	-2,601 Reduced 45.27%	3,144 $283,000
Q2 2021 Aug 13, 2021	BUY	$66.8 - $100.45 $107,080 - $161,021	1,603 Added 38.7%	5,745 $530,000
Q1 2021 May 14, 2021	BUY	$59.3 - $183.85 $245,620 - $761,506	4,142 New	4,142 $400,000

200

16M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $513M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.